Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and ...

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call March 19, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...

Doctors dismissed my cancer symptoms as stress and gas — so I built an AI that can catch it sooner and personalize treatment

Someday soon, doctors who don’t run their patients’ records through an AI model will be considered negligent. At least, that’s what Steve Brown thinks. He’s the founder of CureWise, an app designed to ...